EPHA2 and gastric cancer: Expressions of both EphA2 and ephrinA1 on the basis of the mRNA level or immunohistochemical analysis have been demonstrated to be higher in gastric cancer than in normal tissue, and EphA2 was significantly associated with poor survival, whereas ephrinA1 was not [13].